Advent Technologies Announces the Appointment of Dr. Nora Gourdoupi to its Board of Directors
July 22 2022 - 5:01PM
Business Wire
Advent Technologies Holdings, Inc. (NASDAQ: ADN) (“Advent” or
the “Company”), an innovation-driven leader in the fuel cell and
hydrogen technology space, proudly announces that Dr. Panoraia
‘Nora’ Gourdoupi has agreed to join its board of directors.
Dr. Gourdoupi is Advent’s Senior Vice President of Corporate
Business Developments and has been with Advent since its beginning,
joining the Company in 2006 as a Senior Scientist. She is
intimately involved in both developing the polymers which form the
heart of the Company’s MEA and fuel cell products, as well as
acting as a vital liaison to both government and industry partners.
Dr. Gourdoupi holds a Bachelor of Sciences in Chemistry and a PhD
from the University of Patras, specializing in the synthesis and
characterization of polymers for fuel cell applications. She is
co-inventor of eighteen patents in the field.
“Without Nora’s innovation and dedication to our technology, we
would not have a best in class MEA powering a portfolio of fuel
cell products poised to revolutionize how energy is created,” said
Dr. Vasilis Gregoriou, Advent’s Chief Executive Officer and
Chairman. “Without her tireless advocacy and diligence in working
with the European Commission over the past eighteen months, Advent
would not have received the approval and ratification of Green
HiPo, a colossal project which will transform the Company and
ensure that Advent is positioned among the world leaders in green
energy technology. I welcome her to the board.”
“My entire professional career has been dedicated to developing
efficient, cost-effective fuel cells to create clean energy,” said
Dr. Gourdoupi. “From my start at the Company more than fifteen
years ago as a Senior Scientist to now as I join its board of
directors, I have always known that Advent’s best in class
technology and world class team will power the green energy
revolution. With the Green HiPo project approved and ratified, the
widespread adoption of fuel cells as a truly viable fossil fuel
alternative is closer than ever.”
Dr. Gourdoupi will assume the remainder of Dr. Christos
Kaskavelis’ Class III term as director. Dr. Kaskavelis resigned
from the Advent board on July 19, 2022. He will remain with the
Company as its Chief Marketing Officer. Dr. Kaskavelis stated “With
Nora shepherding the approval and ratification of Green HiPo, I am
thrilled that she will now join our board of directors. I have
known Nora for many years and cannot imagine any other potential
board member who could combine her scientific acumen with her
proven dedication to the Company. I look forward to focusing
completely on my role as an executive at Advent, and I welcome the
opportunity to assist Nora in any way possible as she joins the
board.”
About Advent Technologies Holdings, Inc.
Advent Technologies Holdings, Inc. is a U.S. corporation that
develops, manufactures, and assembles complete fuel cell systems as
well as supplying customers with critical components for fuel cells
in the renewable energy sector. Advent is headquartered in Boston,
Massachusetts, with offices in California, Greece, Denmark,
Germany, and the Philippines. With more than 150 patents issued,
pending, and licensed for fuel cell technology, Advent holds the IP
for next-generation HT-PEM that enables various fuels to function
at high temperatures and under extreme conditions – offering a
flexible “Any Fuel. Anywhere.” option for the automotive, aviation,
defense, oil and gas, marine, and power generation sectors. For
more information, visit www.advent.energy.
Cautionary Note Regarding Forward-Looking Statements
This press release includes forward-looking statements. These
forward-looking statements generally can be identified by the use
of words such as “anticipate,” “expect,” “plan,” “could,” “may,”
“will,” “believe,” “estimate,” “forecast,” “goal,” “project,” and
other words of similar meaning. Each forward-looking statement
contained in this press release is subject to risks and
uncertainties that could cause actual results to differ materially
from those expressed or implied by such statement. Applicable risks
and uncertainties include, among others, the Company’s ability to
maintain the listing of the Company’s common stock on Nasdaq;
future financial performance; public securities’ potential
liquidity and trading; impact from the outcome of any known and
unknown litigation; ability to forecast and maintain an adequate
rate of revenue growth and appropriately plan its expenses;
expectations regarding future expenditures; future mix of revenue
and effect on gross margins; attraction and retention of qualified
directors, officers, employees and key personnel; ability to
compete effectively in a competitive industry; ability to protect
and enhance Advent’s corporate reputation and brand; expectations
concerning its relationships and actions with technology partners
and other third parties; impact from future regulatory, judicial
and legislative changes to the industry; ability to locate and
acquire complementary technologies or services and integrate those
into the Company’s business; future arrangements with, or
investments in, other entities or associations; and intense
competition and competitive pressure from other companies worldwide
in the industries in which the Company will operate; and the risks
identified under the heading “Risk Factors” in Advent’s Annual
Report on Form 10-K filed with the Securities and Exchange
Commission (“SEC”) on March 31, 2022, as well as the other
information filed with the SEC. Investors are cautioned not to
place considerable reliance on the forward-looking statements
contained in this press release. You are encouraged to read
Advent’s filings with the SEC, available at www.sec.gov, for a
discussion of these and other risks and uncertainties. The
forward-looking statements in this press release speak only as of
the date of this document, and the Company undertakes no obligation
to update or revise any of these statements. Advent’s business is
subject to substantial risks and uncertainties, including those
referenced above. Investors, potential investors, and others should
give careful consideration to these risks and uncertainties.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220722005457/en/
Elisabeth Maragoula/Michael Trontzos Advent Technologies
Holdings, Inc. press@advent.energy
Advent Technologies (NASDAQ:ADN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Advent Technologies (NASDAQ:ADN)
Historical Stock Chart
From Apr 2023 to Apr 2024